Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

3.53
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
2.67
Today|||52-Week Range
5.10
+32.21%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues40.4K78.4K9.4K30.9K
 
 
 
 
 
Cost of Goods Sold35.8K45.2K26.6K32.7K
 
 
 
 
 
Depreciation And Amortization1.3K288.00288.00289.00
 
 
 
 
 
 
Operating ExpensesGross Income3.3K32.9K-17.5K-2.1K
 
 
 
 
 
General Expenses2.8M2.8M2.6M4.6M
 
 
 
 
 
Research And Development1.6M1.7M1.6M2.2M
 
 
 
 
 
Total Operating Expenses2.8M2.8M2.6M4.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.8M-2.8M-2.6M-4.6M
 
 
 
 
 
Interest Expense On Debt49.5K51.5K108.2K15.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.8M-2.8M-2.7M-4.6M
 
 
 
 
 
Net Income-2.8M-2.8M-2.7M-4.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS49.1M49.7M51.5M53.3M
 
 
 
 
 
Shares To Calculate EPS Diluted49.1M49.7M51.5M53.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.05-$0.06-$0.05-$0.09
 
 
 
 
 
EPS Diluted-$0.06-$0.06-$0.05-$0.09